Compounds > 4-hydroxyifosfamide
Page last updated: 2024-09-03

4-hydroxyifosfamide and Carcinoma, Non-Small Cell Lung

4-hydroxyifosfamide has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurowski, V; Wagner, T1
Brüggemann, SK; Kisro, J; Wagner, T1

Trials

1 trial(s) available for 4-hydroxyifosfamide and Carcinoma, Non-Small Cell Lung

ArticleYear
Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
    Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged

1997

Other Studies

1 other study(ies) available for 4-hydroxyifosfamide and Carcinoma, Non-Small Cell Lung

ArticleYear
Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
    Cancer research, 1997, Jul-01, Volume: 57, Issue:13

    Topics: Acetaldehyde; Carcinoma, Non-Small-Cell Lung; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Ifosfamide; Kidney Tubules; Lung Neoplasms; Tumor Cells, Cultured

1997